Gregory Michael Lucas, M.D., Ph.D.

Headshot of Gregory Michael Lucas
  • Professor of Medicine
Male

Expertise

HIV/AIDS, Infectious Disease

Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment

Locations

The Johns Hopkins Hospital (Main Entrance)

Appointment Phone: 410-955-1725
1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287
The Johns Hopkins Hospital (Main Entrance) - Google Maps

Background

Dr. Gregory M. Lucas is an associate professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS and infectious disease. 

Dr. Lucas received his undergraduate degree from the University of Notre Dame. He earned his M.D. from Duke University School of Medicine and his Ph.D. from Johns Hopkins. He completed his residency and performed a fellowship in infectious diseases at Johns Hopkins.

He serves on the faculties of the Center for AIDS Research, where he is co-director of the Substance Use Scientific Working Group; the Center for Substance Abuse Treatment and Research; the Center for Adolescent Health; and the Heart and Vascular Institute.

...read more

Education

Degrees

  • MD; Duke University School of Medicine (1994)

Residencies

  • Internal Medicine; Johns Hopkins University School of Medicine (1997)

Fellowships

  • Infectious Diseases; Johns Hopkins University School of Medicine (2001)

Board Certifications

  • American Board of Internal Medicine (Infectious Disease) (2000)

Research & Publications

Selected Publications

Waheed S, Sakr A, Chheda ND, Lucas GM, Estrella M, Fine DM, Atta MG. “Outcomes of Renal Transplantation in HIV-1 Associated Nephropathy.” PLoS One. 2015 Jun 10;10(6):e0129702. doi: 10.1371/journal.pone.0129702. eCollection 2015.

Murakami CA, Attia D, Carter-Monroe N, Lucas GM, Estrella MM, Fine DM, Atta MG. “The clinical characteristics and pathological patterns of postinfectious glomerulonephritis in HIV-infected patients.” PLoS One. 2014 Oct 1;9(10):e108398. doi: 10.1371/journal.pone.0108398. eCollection 2014.

Bhasin B, Lau B, Atta MG, Fine DM, Estrella MM, Schwartz GJ, Lucas GM. “HIV viremia and T-cell activation differentially affect the performance of glomerular filtration rate equations based on creatinine and cystatin C.” PLoS One. 2013 Dec 23;8(12):e82028. doi: 10.1371/journal.pone.0082028. eCollection 2013.

Foy MC, Estrella MM, Lucas GM, Tahir F, Fine DM, Moore RD, Atta MG. “Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy.” Clin J Am Soc Nephrol. 2013 Sep;8(9):1524-32. doi: 10.2215/CJN.10991012. Epub 2013 May 16.

Lambert AA, Drummond MB, Mehta SH, Brown TT, Lucas GM, Kirk GD, Estrella MM. “Risk factors for vitamin D deficiency among HIV-infected and uninfected injection drug users.” PLoS One. 2014 Apr 22;9(4):e95802. doi: 10.1371/journal.pone.0095802. eCollection 2014.

Atta MG, Lucas GM, Fine DM. “HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management.” Expert Rev Anti Infect Ther. 2008 Jun;6(3):365-71. doi: 10.1586/14787210.6.3.365. Review.

Atta MG, Estrella MM, Kuperman M, Foy MC, Fine DM, Racusen LC, Lucas GM, Nelson GW, Warner AC, Winkler CA, Kopp JB. “HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.” Kidney Int. 2012 Aug;82(3):338-43. doi: 10.1038/ki.2012.111. Epub 2012 Apr 11.

Is this you? Edit Profile
back to top button